RxDoctor Payments Data

Keith Cook

Foot & Ankle Surgery · Newark, NJNPI 1235243106

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (45.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Medical Device Business Services, Inc. at 42.2% of the total. Reporting peaked in 2022 at $23,234 and has fallen 82.0% since, to $4,183 in 2025. Among foot & ankle surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$78,021in general payments, 2019–2025

Across 158 payments — averaging $493.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$33K
  • Osteomed LLC$25K
  • Acumed LLC$14K
  • Ossio Inc$1K
  • Stryker$1K
  • Musculoskeletal Transplant Foundation Inc.$1K
  • plus $3K from 18 others

What the payments were for

  • Royalty or licence$35,07845%
  • Consulting fees$31,24740%
  • Speaking & faculty fees$1,5002%
  • Travel & lodging$2,6833%
  • Food & beverage$7,3039%
  • Education$2100%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$78,021 in reported general payments places this provider in the 95th percentile of 542 foot & ankle surgery providers in New Jersey.

See all foot & ankle surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$10,083
Medicare patients
61
Services billed
133

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate85$1,784
Ciclopirox21$924
Clotrimazole26$483
Clindamycin Phosphate12$315

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Newark

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →